logo-loader
OTCQB:CYDY

CytoDyn Inc.

Receive alerts
Market:
OTCQB
Price
0.17 USD
Day Change
0.04%
Market Cap:
$163.58 m
52 weeks high
0.42
52 weeks low
0.15

In brief

CytoDyn Inc is a Vancouver, Washington-based late-stage biotechnology company that is developing Vyrologix (leronlimab or PRO 140) to battle multiple diseases. Most significantly, it is working to develop a significant advance in HIV treatment beyond the “AIDS cocktail” combination of pills that has kept millions of people alive since the mid-1990s. Vyrologix has been granted Fast Track designation by the FDA for the treatment of HIV in combination with the cocktail known as highly active antiretroviral therapy (HAART) and for metastatic triple-negative breast cancer, which a rare variety of the condition that doesn’t respond to some treatments. CytoDyn is also exploring Vyrologix's use in the treatment of cancer, inflammatory conditions, autoimmune diseases and even the coronavirus (COVID-19).